Sagespring Wealth Partners LLC Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Sagespring Wealth Partners LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 7.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,133 shares of the healthcare conglomerate’s stock after selling 1,381 shares during the period. Sagespring Wealth Partners LLC’s holdings in UnitedHealth Group were worth $8,450,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Norges Bank acquired a new position in UnitedHealth Group in the fourth quarter valued at $6,375,744,000. GAMMA Investing LLC increased its stake in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares during the period. Raymond James Financial Inc. acquired a new position in shares of UnitedHealth Group during the fourth quarter worth about $1,914,740,000. Amundi increased its stake in shares of UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after buying an additional 2,301,010 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $313.39 on Monday. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The firm has a fifty day moving average of $386.66 and a 200-day moving average of $472.32. The firm has a market capitalization of $284.28 billion, a P/E ratio of 20.22, a PEG ratio of 1.37 and a beta of 0.44. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the company earned $6.91 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.82%. The ex-dividend date is Monday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on UNH shares. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. TD Securities restated a “hold” rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Baird R W downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a report on Tuesday, June 3rd. Finally, Erste Group Bank downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $426.52.

View Our Latest Analysis on UNH

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer now directly owns 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the firm’s stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.